• Joshua Petrie PhD, MPH

  • Associate Research Scientist

    • MCRI - MCRI-Clin Epidem and Pop Hlth
    • 1000 North Oak Ave. ML2 Marshfield, WI 54449


2012 to 2016:
PhD, Epidemiologic Science, University of Michigan School of Public Health, Ann Arbor, MI
2006 to 2008:
MPH, Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
2001 to 2004:
BS, Biology, University of Michigan, Ann Arbor, MI

Work Experience

2022 to Present:
Associate Research Scientist, Marshfield Clinic Research Institute, Marshfield, WI
2019 to 2021:
Research Assistant Professor, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
2016 to 2019:
Research Investigator, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
2012 to 2016:
Graduate Student Research Assistant, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
2008 to 2012:
Research Area Specialist, Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI


Dr. Petrie is an infectious disease epidemiologist and Associate Research Scientist in the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute. His research focuses on the epidemiology and transmission influenza, SARS-CoV-2, and other respiratory viruses. This has included studies of vaccine effectiveness, the duration of vaccine induced protection, and immune correlates of protection. His current projects are focused on the incidence, clinical outcomes, and molecular epidemiology of hospital-associated respiratory virus infections.

Research Interests

Infectious disease epidemiology
Respiratory viruses
Hospital-acquired infections
Vaccine effectiveness
Immune correlates of protection
Duration of immunity

Select Publications

  • Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E,...Victor JC. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med. 361(13):1260-7.
    PubMed ID: 19776407
  • Ohmit SE, Petrie JG, Cross RT, Johnson E, Monto AS. Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 204(12):1879-85.
    PubMed ID: 21998477
  • Petrie JG, Ohmit SE, Johnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis. 203(9):1309-15. PMCID: PMC3069734.
    PubMed ID: 21378375
  • Petrie JG, Ohmit SE, Cowling BJ, Johnson E, Cross RT, Malosh RE,...Monto AS. Influenza transmission in a cohort of households with children: 2010-2011. PLoS One. 2013 October; 8(9):e75339. PMCID: PMC3783407.
    PubMed ID: 24086511
  • Ohmit SE, Petrie JG, Malosh RE, Cowling BJ, Thompson MG, Shay DK, Monto AS. Influenza vaccine effectiveness in the community and the household. Clin Infect Dis. 56(10):1363-9. PMCID: PMC3693492.
    PubMed ID: 23413420
  • Petrie JG, Ohmit SE, Johnson E, Truscon R, Monto AS. Persistence of Antibodies to Influenza Hemagglutinin and Neuraminidase Following One or Two Years of Influenza Vaccination. J Infect Dis. 212(12):1914-22. PMCID: PMC4655854.
    PubMed ID: 26014800
  • Monto AS, Petrie JG, Cross RT, Johnson E, Liu M, Zhong W,...Ohmit SE. Antibody to Influenza Virus Neuraminidase: An Independent Correlate of Protection. J Infect Dis. 212(8):1191-9.
    PubMed ID: 25858957
  • Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK,...Ohmit SE [including King JP.] Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013. Clin Infect Dis. 2016 February 15; 62(4):448-455.
    PubMed ID: 26565004
  • Petrie JG, Parkhouse K, Ohmit SE, Malosh RE, Monto AS, Hensley SE. Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains. J Infect Dis. 2016 December 15; 214(12):1947-1951. PMCID: PMC5142093.
    PubMed ID: 27923954
  • Petrie JG, Ohmit SE, Cheng CK, Martin ET, Malosh RE, Lauring AS,...Monto AS. Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. Clin Infect Dis. 63(8):1017-25.
    PubMed ID: 27369320
  • Petrie JG, Ohmit SE, Truscon R, Johnson E, Braun TM, Levine MZ,...Monto AS. Modest Waning of Influenza Vaccine Efficacy and Antibody Titers During the 2007-2008 Influenza Season. J Infect Dis. 214(8):1142-9.
    PubMed ID: 27095420
  • Petrie JG, Eisenberg MC, Ng S, Malosh RE, Lee KH, Ohmit SE, Monto AS. Application of an Individual-Based Transmission Hazard Model for Estimation of Influenza Vaccine Effectiveness in a Household Cohort. Am J Epidemiol. 186(12):1380-1388. PMCID: PMC5860432.
    PubMed ID: 28605429
  • Petrie JG, Malosh RE, Cheng CK, Ohmit SE, Martin ET, Johnson E,...Monto AS. The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014-2015 Influenza Vaccine. Clin Infect Dis. 65(10):1644-1651. PMCID: PMC5850544.
    PubMed ID: 29020179
  • Petrie JG, Monto AS. Untangling the Effects of Prior Vaccination on Subsequent Influenza Vaccine Effectiveness. J Infect Dis. 215(6):841-843.
    PubMed ID: 28453852
  • Petrie JG, Gordon A. Epidemiological Studies to Support the Development of Next Generation Influenza Vaccines. Vaccines (Basel). 2018 March 26; 6(2) PMCID: PMC6027373.
    PubMed ID: 29587412
  • Petrie JG, Martin ET, Zhu Y, Wyatt DG, Kaniclides A, Ferdinands JM,...Talbot HK. Comparison of a frailty short interview to a validated frailty index in adults hospitalized for acute respiratory illness. Vaccine. 37(29):3849-3855. PMCID: PMC8564875.
    PubMed ID: 31113675
  • Zelner J, Petrie JG, Trangucci R, Martin ET, Monto AS. Effects of Sequential Influenza A(H1N1)pdm09 Vaccination on Antibody Waning. J Infect Dis. 220(1):12-19. PMCID: PMC6548909.
    PubMed ID: 30722022
  • Gilbert PB, Fong Y, Juraska M, Carpp LN, Monto AS, Martin ET, Petrie JG. HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy. BMC Infect Dis. 2019 May 22; 19(1):453. PMCID: PMC6530189.
    PubMed ID: 31117986
  • Petrie JG, Martin ET, Truscon R, Johnson E, Cheng CK, McSpadden EJ,...Monto AS. Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population. Vaccine. 37(10):1284-1292. PMCID: PMC6595494.
    PubMed ID: 30738647
  • Monto AS, DeJonge PM, Callear AP, Bazzi LA, Capriola SB, Malosh RE,...Petrie JG. Coronavirus Occurrence and Transmission Over 8 Years in the HIVE Cohort of Households in Michigan. J Infect Dis. 222(1):9-16. PMCID: PMC7184402.
    PubMed ID: 32246136
  • Petrie JG, Lauring AS, Martin ET, Kaye KS. Hospital Associated Respiratory Virus Infection in Children and Adults: It Does Not Just Occur During Cold and Flu Season. Open Forum Infect Dis. 2020 June; 7(6):ofaa200. PMCID: PMC7314589.
    PubMed ID: 32617374
  • Petrie JG, Talbot TR. Health Care-Acquired Viral Respiratory Diseases. Infect Dis Clin North Am. 35(4):1055-1075.
    PubMed ID: 34752220
  • Petrie JG, Fligiel H, Lamerato L, Martin ET, Monto AS. Agreement between state registry, health record, and self-report of influenza vaccination. Vaccine. 39(38):5341-5345. PMCID: PMC8452147.
    PubMed ID: 34384635
  • Petrie JG, Bazzi LA, McDermott AB, Follmann D, Esposito D, Hatcher C,...Monto AS. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses. J Infect Dis. 224(1):49-59. PMCID: PMC8083771.
    PubMed ID: 33755731
  • Bailey JM, Wang L, McDonald JM, Gray JS, Petrie JG, Martin ET,...Wasilevich EA. Immune response to COVID-19 vaccination in a population with a history of elevated exposure to per- and polyfluoroalkyl substances (PFAS) through drinking water. J Expo Sci Environ Epidemiol. 2023 September;33(5):725-736. doi: 10.1038/s41370-023-00564-8. PMCID: PMC10541329.
    PubMed ID: 37337047
  • Smith-Jeffcoat SE, Biddle JE, Talbot HK, Morrisey KG, Stockwell MS, Maldonado Y,...Belongia, Ed [including McLean HQ, Petrie JG.] Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals. Clin Infect Dis. 2024 May 15;78(5):1175-1184. doi: 10.1093/cid/ciad696.
    PubMed ID: 37963102
  • Petrie JG, Moore R, Lauring AS, Kaye KS. Incidence and outcomes of hospital-associated respiratory virus infections by viral species. Infect Control Hosp Epidemiol. 2024 May;45(5):618-629. doi: 10.1017/ice.2023.263.
    PubMed ID: 38073596
  • Belongia EA, Petrie JG, Feldstein LR, Guan L, Halfmann PJ, King JP,...Kawaoka Y [including McLean HQ.] Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection. J Pediatric Infect Dis Soc. 2024 January 29;13(1):100-104. doi: 10.1093/jpids/piad109.
    PubMed ID: 38142128
  • Wangchinda W, Kaye KS, Patel TS, Albin OR, Saravolatz L, Petrie JG, Pogue JM. A comparison of strategies for identifying patients at risk for carbapenem-resistant or extended ß-lactam-resistant Pseudomonas aeruginosa. J Antimicrob Chemother. 2024 June 3;79(6):1337-1345. doi: 10.1093/jac/dkae104.
    PubMed ID: 38581308
  • Pattinson D, Jester P, Gu C, Guan L, Armbrust T, Petrie JG,...Kawaoka Y [including King JP, Nguyen HQ, Belongia EA.] Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses. EBioMedicine. 2024 May;103:105103. doi: 10.1016/j.ebiom.2024.105103.
    PubMed ID: 38574407
  • Petrie JG, Pattinson D, King JP, Neumann G, Guan L, Jester P,...Nguyen HQ [including Meece JK, Kieke BA, Belongia EA.] SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020 - July 2022. [published online ahead of print 2024 June 17]. Am J Epidemiol. kwae125. doi: 10.1093/aje/kwae125.
    PubMed ID: 38885957